IV Oxytocin

DRUG2 trials

Sponsors

GlaxoSmithKline, Stony Brook University

Conditions

Postpartum Hemorrhage

Phase 1

Comparison of Inhaled Oxytocin (IH) With Intramuscular (IM) Oxytocin in Pregnant Women and With Intravenous (IV) Oxytocin in Healthy Non-pregnant Women

TerminatedNCT02999100

GlaxoSmithKlinePostpartum Hemorrhage

Start: 2016-11-23End: 2019-03-04Updated: 2020-03-23

Phase 3

Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage

RecruitingNCT05245227

Stony Brook UniversityPostpartum Hemorrhage

Start: 2025-01-27End: 2027-01-01Target: 1358Updated: 2025-05-04

Related Papers

Application of immunocapture and nanoflow LC–MS/MS to overcome the barriers to the quantitation of oxytocin in plasma of women in third stage labour

British Journal of Clinical Pharmacology2024-06-183 citations